Shares in Irish biotech company Elan jumped yesterday on rumours Denmark’s Lundbeck was preparing to launch a €8 per share bid.

Speculation over Elan has been bubbling since the company engaged Citigroup in January to advise it on a strategic review to secure access to fresh funds.